These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19545055)

  • 1. [Pharmacophore model of integrin alphavbeta3 antagonists].
    Cheng GY; Ni GH; Jiang FC
    Yao Xue Xue Bao; 2009 Apr; 44(4):379-85. PubMed ID: 19545055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Design and activity determination of small molecular inhibitors of integrin alphavbeta3].
    Ji Q; Zhou Y; Peng H; Huang N; Qi J; Xiong DS; Gao YD; Yang M; Yang CZ
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Jun; 29(3):347-52. PubMed ID: 17633460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of small molecule integrin alphavbeta3 antagonists as novel anticancer agents.
    Dayam R; Aiello F; Deng J; Wu Y; Garofalo A; Chen X; Neamati N
    J Med Chem; 2006 Jul; 49(15):4526-34. PubMed ID: 16854058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part 1: design and synthesis of a lead compound exhibiting alpha(v)beta3/alpha(IIb)beta3 dual antagonistic activity.
    Kubota D; Ishikawa M; Yamamoto M; Murakami S; Hachisu M; Katano K; Ajito K
    Bioorg Med Chem; 2006 Apr; 14(7):2089-108. PubMed ID: 16309911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3D-pharmacophore models for selective A2A and A2B adenosine receptor antagonists.
    Wei J; Wang S; Gao S; Dai X; Gao Q
    J Chem Inf Model; 2007; 47(2):613-25. PubMed ID: 17330954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tricyclic pharmacophore-based molecules as novel integrin alphavbeta3 antagonists. Part IV: preliminary control of alphavbeta3 selectivity by meta-oriented substitution.
    Kubota D; Ishikawa M; Ishikawa M; Yahata N; Murakami S; Fujishima K; Kitakaze M; Ajito K
    Bioorg Med Chem; 2006 Jun; 14(12):4158-81. PubMed ID: 16504518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of a new class of selective integrin alpha5beta1 antagonists.
    Stragies R; Osterkamp F; Zischinsky G; Vossmeyer D; Kalkhof H; Reimer U; Zahn G
    J Med Chem; 2007 Aug; 50(16):3786-94. PubMed ID: 17616113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical function based pharmacophore generation of endothelin-A selective receptor antagonists.
    Funk OF; Kettmann V; Drimal J; Langer T
    J Med Chem; 2004 May; 47(11):2750-60. PubMed ID: 15139753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3D-pharmacophore model for RXR(gamma) agonists.
    Dong A; Wei J; Gao Q
    Neurochem Int; 2009; 54(5-6):286-91. PubMed ID: 19121355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction and application of pharmacophore model of benzoylurea derivatives as beta-tubulin inhibitors].
    Gao LM; Zhang SH; Yi H; Jiang JD; Song DQ
    Yao Xue Xue Bao; 2010 Apr; 45(4):462-6. PubMed ID: 21355210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part 2: synthesis of potent alpha(v)beta3/alpha(IIb)beta3 dual antagonists.
    Ishikawa M; Kubota D; Yamamoto M; Kuroda C; Iguchi M; Koyanagi A; Murakami S; Ajito K
    Bioorg Med Chem; 2006 Apr; 14(7):2109-30. PubMed ID: 16309912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tricyclic pharmacophore-based molecules as novel integrin alpha(v)beta3 antagonists. Part III: synthesis of potent antagonists with alpha(v)beta3/alpha(IIb)beta3 dual activity and improved water solubility.
    Ishikawa M; Hiraiwa Y; Kubota D; Tsushima M; Watanabe T; Murakami S; Ouchi S; Ajito K
    Bioorg Med Chem; 2006 Apr; 14(7):2131-50. PubMed ID: 16307881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel short chain 4-substituted indoles as potent alphavbeta3 antagonist using structure-based drug design.
    Raboisson P; Desjarlais RL; Reed R; Lattanze J; Chaikin M; Manthey CL; Tomczuk BE; Marugán JJ
    Eur J Med Chem; 2007 Mar; 42(3):334-43. PubMed ID: 17184884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-peptide angiotensin II receptor antagonists: chemical feature based pharmacophore identification.
    Krovat EM; Langer T
    J Med Chem; 2003 Feb; 46(5):716-26. PubMed ID: 12593652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of small molecule inhibitors of integrin alphavbeta3 through structure-based virtual screening.
    Zhou Y; Peng H; Ji Q; Qi J; Zhu Z; Yang C
    Bioorg Med Chem Lett; 2006 Nov; 16(22):5878-82. PubMed ID: 16982193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of predictive pharmacophore models for CCR5 antagonists: study with piperidine- and piperazine-based compounds as a new class of HIV-1 entry inhibitors.
    Debnath AK
    J Med Chem; 2003 Oct; 46(21):4501-15. PubMed ID: 14521412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-Aryl-gamma-lactams as integrin alphavbeta3 antagonists.
    Xi N; Arvedson S; Eisenberg S; Han N; Handley M; Huang L; Huang Q; Kiselyov A; Liu Q; Lu Y; Nunez G; Osslund T; Powers D; Tasker AS; Wang L; Xiang T; Xu S; Zhang J; Zhu J; Kendall R; Dominguez C
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2905-9. PubMed ID: 15125957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Construction of the pharmacophore model of acetylcholinesterase inhibitor.
    Zhu Y; Tong XY; Zhao Y; Chen H; Jiang FC
    Yao Xue Xue Bao; 2008 Mar; 43(3):267-76. PubMed ID: 18630262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand-based pharmacophore model of N-Aryl and N-Heteroaryl piperazine alpha 1A-adrenoceptors antagonists using GALAHAD.
    Zhao X; Yuan M; Huang B; Ji H; Zhu L
    J Mol Graph Model; 2010 Sep; 29(2):126-36. PubMed ID: 20538497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacophore modeling as an efficient tool in the discovery of novel noncompetitive AMPA receptor antagonists.
    Barreca ML; Gitto R; Quartarone S; De Luca L; De Sarro G; Chimirri A
    J Chem Inf Comput Sci; 2003; 43(2):651-5. PubMed ID: 12653534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.